07 Sep 2016
LIBERUM: Shield Therapeutics* - Major positive: first composition patent grant, PT upgraded
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
LIBERUM: Shield Therapeutics* - Major positive: first composition patent grant, PT upgraded
Shield Therapeutics Plc (STX:LON) | 2.0 0 0.0% | Mkt Cap: 15.8m
- Published:
07 Sep 2016 -
Author:
Roger Franklin -
Pages:
3